Outcome Study Following Reimbursement Changes in the Use of Fixed Combination Inhalers in Patients With Asthma or Chronic Obstructive Pulmonary Disease

AstraZeneca

Status: Completed

Conditions: Asthma; Chronic Obstructive Pulmonary Disease

Study type: Observational

Funder types: Industry

Identifiers

NCT01369810

NIS-RSE-DUM-2010/2

Details and patient eligibility

About

To investigate how a switch from fixed combination treatment (ICS and LABA) to other treatments influence asthma or COPD treatment failure

Enrollment: 20,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• All patients who was on treatment with fixed combination asthma or COPD therapy by January 1 2010

Trial design

20,000 participants in 1 patient group

1

Description:

All patients who was on treatment with fixed combination asthma or COPD therapy by January 1 2010